HOME › DRUGS › MOSUNETUZUMAB
ACTIVE SUBSTANCE / INN

MOSUNETUZUMAB

Brand name(s): Lunsumio
EMA LISTED
AUTHORISED
Lymphoma, Follicular
ACTIVE SUBSTANCE
Mosunetuzumab
REGULATORS
EMA
SPONSORS / MAH
Roche Registration GmbH
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
LunsumioRoche Registration GmbHAuthorised03/06/2022Lymphoma, Follicular

FULL INTELLIGENCE ON MOSUNETUZUMAB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →